The share of UK scientific publications in the top 10% most-cited in Immunology and Allergy is projected to slightly increase from 14.73% in 2024 to 14.75% by 2028. This suggests a stable but marginal growth rate over the forecasted period. In 2023, this share stood, likely reflecting a consistent performance in global academic influence within these fields of study.
- The year-on-year variation is minimal, highlighting little change annually. - The compound annual growth rate (CAGR) over these five years indicates a steady trajectory without significant fluctuations.
Future trends to watch include potential impacts from increased funding or breakthroughs in immunological research, which may enhance publication influence. Additionally, shifts in global research dynamics or policy changes in the UK could alter these steady growth patterns.
